跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 171 条关于
“RI-AG03”
全部
171
临床试验
98
药物
54
机构
1
资讯
18
去年
RI-AG03: Novel Drug Targets Tau Protein Hotspots, Showing Promise in Alzheimer's Research
2年前
Canadian Institutes of Health Research Funds Four New Clinical Trials at RI-MUHC
9天前
NIH Awards $26M to Advance RI-CTR for Third Five-Year Phase of Clinical and Translational Research
2年前
A New Hope for Men with Metastatic Prostate Cancer
4个月前
Onco-Innovations Advances Polymer Testing for PNKP Inhibitor Technology Ahead of IND-Enabling Studies
11天前
Veru Advances Oral Sabizabulin After Preclinical Data Show Potent Activity in Daraxonrasib-Resistant Pancreatic Cancer
2个月前
Summit Therapeutics Sells Phase III Antibiotic Ridinilazole to AI-Native Biossil in Deal Worth Up to $104.5 Million
2年前
Camonsertib Shows Promise in ATM-Deficient Advanced Solid Tumors
去年
Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease
2个月前
Agomab Unveils Design for First-Ever Phase 2b Trial in Fibrostenosing Crohn's Disease with Oral ALK5 Inhibitor Ontunisertib
第 1 页,共 2 页
上一页
下一页